プレスリリース

Illumina to Webcast Upcoming Investor Conference Presentations

SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.

Evercore ISI HealthCONx Conference in Boston, MA
Wednesday, December 4, 2019 at 8:45am Eastern Time

Piper Jaffray Annual Healthcare Conference in New York, NY
Thursday, December 5, 2019 at 10:30am Eastern Time

The live webcasts can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com. A replay of the presentations will be posted on Illumina’s website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

Investors:
Jacquie Ross, CFA
858-882-2172
ir@illumina.com

Media:
Eric Endicott
858-882-6822
pr@illumina.com

Source: Illumina, Inc.

最近の記事

社員が達成したイルミナのマイルストーン:ボランティア活動10万時間
社員が達成したイルミナのマイルストーン:ボランティア活動10万時間
The Sequence Podcast EP 1:世界のゲノミクスリーダーの舞台裏
The Sequence Podcast EP 1:世界のゲノミクスリーダーの舞台裏
ゲノミクスが薬剤耐性結核の早期検出にどのように役立つか
Video: ゲノミクスが薬剤耐性結核の早期検出にどのように役立つか